07 Jan 2001

Ulcogant®-IC (Ulcogant®-IC Suspension) - Deutschland

Updated: 07 Jan 2001

Ulcogant®-IC

Prophylaxe streßbedingter Schleimhautläsionen im oberen Intestinaltrakt b. Intensivpflegepatienten unter strenger Nutzen-Risiko-Abwägung, wenn schwere Komplikationen dieser Schleimhautläsionen zu erwarten sind.

Ulcogant®-IC Description, Presentation and Dosage

Ulcogant®-IC Description

Ulcogant®-IC Drug Class Description

Andere Gastritis-/Ulkusmittel

Ulcogant®-IC Drug Description

5 ml Suspension enth.: Sucralfat 1 g (entspr. 190 mg Aluminium).

Ulcogant®-IC Generic Name

Ulcogant®-IC Suspension

Ulcogant®-IC Presentation

Ulcogant®-IC Presentation

Ulcogant®-IC

Ulcogant®-IC Manufacturer

Merck

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Ulcogant®-IC Dosage

Ulcogant®-IC Adult Dosage

Methyl- u. Propyl-4-hydroxybenzoat jeweils als Natriumsalz (Parabene), Saccharin-Natrium, Aromastoffe, Natriumdihydrogenphosphat, Xanthan Gummi, Glycerol.

Ulcogant®-IC Precautions, Reactions and Contraindications

Ulcogant®-IC Special Precautions

Ulcogant®-IC Special Precautions

Pat. n. Operationen im oberen Gastrointestinaltrakt.

Ulcogant®-IC Adverse Reactions

Ulcogant®-IC Adverse Reactions

Strenge Ind.-Stellung Gr 4 .

Related Drugs - Gastroenterology

Back to top